VASCONCELLES MICHAEL 4
4 · Magenta Therapeutics, Inc. · Filed Aug 17, 2022
Insider Transaction Report
Form 4
VASCONCELLES MICHAEL
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-08-15+40,000→ 40,000 totalExercise: $1.77Exp: 2032-08-14→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]This option shall vest and become exercisable over three years, with 33% of this option vesting on August 15, 2023, and the remainder vesting in 24 equal monthly installments thereafter.